Evidence-Based Management of Anticoagulant TherapyAnne Holbrook, Gordon Guyatt, Sam Schulman et al.|CHEST Journal|2012Cited by 1.3k
Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT)C.Y. VOSSEN, Frits R. Rosendaal, J. Fontcuberta et al.|Journal of Thrombosis and Haemostasis|2005Cited by 202
Familial thrombophilia and lifetime risk of venous thrombosisC.Y. VOSSEN, Frits R. Rosendaal, J. Conard et al.|Journal of Thrombosis and Haemostasis|2004Cited by 105
Recurrence Rate After a First Venous Thrombosis in Patients With Familial ThrombophiliaCarla Y. Vossen, Frits R. Rosendaal, Isobel D. Walker et al.|Arteriosclerosis Thrombosis and Vascular Biology|2005Cited by 105
Hereditary thrombophilia and fetal loss: a prospective follow-up studyC.Y. VOSSEN, Frits R. Rosendaal, F. E. Preston et al.|Journal of Thrombosis and Haemostasis|2004Cited by 89